Bruyer, A., Seckinger, A., Müller-Tidow, C., Goldschmidt, H., & Hose, D. (2018). DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells. British journal of cancer, 118(8), . https://doi.org/10.1038/s41416-018-0025-x
Chicago-Zitierstil (17. Ausg.)Bruyer, Angelique, Anja Seckinger, Carsten Müller-Tidow, Hartmut Goldschmidt, und Dirk Hose. "DNMTi/HDACi Combined Epigenetic Targeted Treatment Induces Reprogramming of Myeloma Cells in the Direction of Normal Plasma Cells." British Journal of Cancer 118, no. 8 (2018). https://doi.org/10.1038/s41416-018-0025-x.
MLA-Zitierstil (9. Ausg.)Bruyer, Angelique, et al. "DNMTi/HDACi Combined Epigenetic Targeted Treatment Induces Reprogramming of Myeloma Cells in the Direction of Normal Plasma Cells." British Journal of Cancer, vol. 118, no. 8, 2018, https://doi.org/10.1038/s41416-018-0025-x.